Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.35
Delayed Data
As of Oct 20
 -0.02 / -0.84%
Today’s Change
1.93
Today|||52-Week Range
4.70
-25.94%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.37
Today’s open2.40
Day’s range2.35 - 2.40
Volume15,253
Average volume (3 months)10,876
Market cap$12.1M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.02-3.60%
CYANCyanotech Corp0.000.00%
IBIOIbio Inc+0.02+5.27%
ISRIsoRay Inc-0.04-6.54%
Data as of 7:59pm ET, 10/20/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts